nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—Vestibular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0226	0.0231	CcSEcCtD
Pregabalin—Tendon disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0174	0.0178	CcSEcCtD
Pregabalin—Gingival hyperplasia—Cyclosporine—focal segmental glomerulosclerosis	0.0169	0.0172	CcSEcCtD
Pregabalin—Salivary gland enlargement—Cyclosporine—focal segmental glomerulosclerosis	0.0164	0.0167	CcSEcCtD
Pregabalin—Toxicity to various agents—Cyclosporine—focal segmental glomerulosclerosis	0.0159	0.0162	CcSEcCtD
Pregabalin—Swollen tongue—Cyclosporine—focal segmental glomerulosclerosis	0.0154	0.0158	CcSEcCtD
Pregabalin—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.0154	CcSEcCtD
Pregabalin—Carcinoma—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.0154	CcSEcCtD
Pregabalin—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.015	CcSEcCtD
Pregabalin—Papilloedema—Cyclosporine—focal segmental glomerulosclerosis	0.0143	0.0146	CcSEcCtD
Pregabalin—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0142	CcSEcCtD
Pregabalin—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.013	0.0133	CcSEcCtD
Pregabalin—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.013	CcSEcCtD
Pregabalin—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0122	CcSEcCtD
Pregabalin—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.00983	0.0101	CcSEcCtD
Pregabalin—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00968	0.0099	CcSEcCtD
Pregabalin—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00968	0.0099	CcSEcCtD
Pregabalin—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.00953	0.00975	CcSEcCtD
Pregabalin—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00939	0.00961	CcSEcCtD
Pregabalin—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00925	0.00947	CcSEcCtD
Pregabalin—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00852	0.00871	CcSEcCtD
Pregabalin—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00841	0.0086	CcSEcCtD
Pregabalin—SLC1A1—nephron tubule—focal segmental glomerulosclerosis	0.00822	0.366	CbGeAlD
Pregabalin—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.0082	0.00839	CcSEcCtD
Pregabalin—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.008	0.00818	CcSEcCtD
Pregabalin—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.008	0.00818	CcSEcCtD
Pregabalin—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00781	0.00799	CcSEcCtD
Pregabalin—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00781	0.00799	CcSEcCtD
Pregabalin—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00772	0.0079	CcSEcCtD
Pregabalin—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00772	0.0079	CcSEcCtD
Pregabalin—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00746	0.00763	CcSEcCtD
Pregabalin—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00746	0.00763	CcSEcCtD
Pregabalin—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.00738	0.00755	CcSEcCtD
Pregabalin—SLC1A1—kidney—focal segmental glomerulosclerosis	0.00723	0.321	CbGeAlD
Pregabalin—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00722	0.00739	CcSEcCtD
Pregabalin—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00714	0.00731	CcSEcCtD
Pregabalin—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00707	0.00723	CcSEcCtD
Pregabalin—SLC1A1—cortex of kidney—focal segmental glomerulosclerosis	0.00704	0.313	CbGeAlD
Pregabalin—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.007	0.00716	CcSEcCtD
Pregabalin—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.007	0.00716	CcSEcCtD
Pregabalin—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00679	0.00695	CcSEcCtD
Pregabalin—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00666	0.00681	CcSEcCtD
Pregabalin—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00653	0.00668	CcSEcCtD
Pregabalin—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00647	0.00662	CcSEcCtD
Pregabalin—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00641	0.00656	CcSEcCtD
Pregabalin—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0063	0.00644	CcSEcCtD
Pregabalin—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00624	0.00638	CcSEcCtD
Pregabalin—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00603	0.00617	CcSEcCtD
Pregabalin—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00588	0.00601	CcSEcCtD
Pregabalin—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00583	0.00596	CcSEcCtD
Pregabalin—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00583	0.00596	CcSEcCtD
Pregabalin—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00578	0.00592	CcSEcCtD
Pregabalin—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00578	0.00592	CcSEcCtD
Pregabalin—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00574	0.00587	CcSEcCtD
Pregabalin—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00531	0.00544	CcSEcCtD
Pregabalin—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00524	0.00536	CcSEcCtD
Pregabalin—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.0052	0.00532	CcSEcCtD
Pregabalin—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00528	CcSEcCtD
Pregabalin—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00528	CcSEcCtD
Pregabalin—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00513	0.00525	CcSEcCtD
Pregabalin—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00506	0.00518	CcSEcCtD
Pregabalin—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00502	0.00514	CcSEcCtD
Pregabalin—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00502	0.00514	CcSEcCtD
Pregabalin—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00499	0.00511	CcSEcCtD
Pregabalin—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00499	0.00511	CcSEcCtD
Pregabalin—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00499	0.00511	CcSEcCtD
Pregabalin—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00499	0.00511	CcSEcCtD
Pregabalin—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00504	CcSEcCtD
Pregabalin—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00504	CcSEcCtD
Pregabalin—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00504	CcSEcCtD
Pregabalin—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.005	CcSEcCtD
Pregabalin—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.005	CcSEcCtD
Pregabalin—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00486	0.00497	CcSEcCtD
Pregabalin—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00477	0.00488	CcSEcCtD
Pregabalin—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00477	0.00488	CcSEcCtD
Pregabalin—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00462	0.00473	CcSEcCtD
Pregabalin—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00454	0.00464	CcSEcCtD
Pregabalin—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00446	0.00456	CcSEcCtD
Pregabalin—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00446	0.00456	CcSEcCtD
Pregabalin—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00438	0.00448	CcSEcCtD
Pregabalin—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00433	0.00443	CcSEcCtD
Pregabalin—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.00441	CcSEcCtD
Pregabalin—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00428	0.00438	CcSEcCtD
Pregabalin—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00436	CcSEcCtD
Pregabalin—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.00427	CcSEcCtD
Pregabalin—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.00424	CcSEcCtD
Pregabalin—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.00424	CcSEcCtD
Pregabalin—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.0042	CcSEcCtD
Pregabalin—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.0042	CcSEcCtD
Pregabalin—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00406	0.00415	CcSEcCtD
Pregabalin—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.00405	CcSEcCtD
Pregabalin—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00394	0.00403	CcSEcCtD
Pregabalin—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00394	0.00403	CcSEcCtD
Pregabalin—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.00395	CcSEcCtD
Pregabalin—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.00387	CcSEcCtD
Pregabalin—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.00384	CcSEcCtD
Pregabalin—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00372	0.0038	CcSEcCtD
Pregabalin—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.00377	CcSEcCtD
Pregabalin—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.00377	CcSEcCtD
Pregabalin—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.00377	CcSEcCtD
Pregabalin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.00375	CcSEcCtD
Pregabalin—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.00373	CcSEcCtD
Pregabalin—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00358	0.00367	CcSEcCtD
Pregabalin—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.00363	CcSEcCtD
Pregabalin—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.0036	CcSEcCtD
Pregabalin—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00351	0.00359	CcSEcCtD
Pregabalin—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00357	CcSEcCtD
Pregabalin—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00356	CcSEcCtD
Pregabalin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.00354	CcSEcCtD
Pregabalin—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.00353	CcSEcCtD
Pregabalin—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.0035	CcSEcCtD
Pregabalin—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00348	CcSEcCtD
Pregabalin—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.00347	CcSEcCtD
Pregabalin—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00345	CcSEcCtD
Pregabalin—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00345	CcSEcCtD
Pregabalin—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.00344	CcSEcCtD
Pregabalin—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.00337	CcSEcCtD
Pregabalin—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.00334	CcSEcCtD
Pregabalin—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00332	CcSEcCtD
Pregabalin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00332	CcSEcCtD
Pregabalin—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.00319	CcSEcCtD
Pregabalin—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.00316	CcSEcCtD
Pregabalin—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.00309	CcSEcCtD
Pregabalin—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.00305	CcSEcCtD
Pregabalin—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00303	CcSEcCtD
Pregabalin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00298	CcSEcCtD
Pregabalin—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00297	CcSEcCtD
Pregabalin—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00293	CcSEcCtD
Pregabalin—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00291	CcSEcCtD
Pregabalin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.00286	CcSEcCtD
Pregabalin—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.0028	CcSEcCtD
Pregabalin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.00272	CcSEcCtD
Pregabalin—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00269	CcSEcCtD
Pregabalin—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.00265	CcSEcCtD
Pregabalin—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.00264	CcSEcCtD
Pregabalin—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00263	CcSEcCtD
Pregabalin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00261	CcSEcCtD
Pregabalin—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.0026	CcSEcCtD
Pregabalin—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.0026	CcSEcCtD
Pregabalin—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00259	CcSEcCtD
Pregabalin—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00256	CcSEcCtD
Pregabalin—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00255	CcSEcCtD
Pregabalin—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00255	CcSEcCtD
Pregabalin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00255	CcSEcCtD
Pregabalin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00253	CcSEcCtD
Pregabalin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00253	CcSEcCtD
Pregabalin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00252	CcSEcCtD
Pregabalin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00252	CcSEcCtD
Pregabalin—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00248	CcSEcCtD
Pregabalin—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.00245	CcSEcCtD
Pregabalin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00244	CcSEcCtD
Pregabalin—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00234	CcSEcCtD
Pregabalin—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00234	CcSEcCtD
Pregabalin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00233	CcSEcCtD
Pregabalin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00233	CcSEcCtD
Pregabalin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00232	CcSEcCtD
Pregabalin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00231	CcSEcCtD
Pregabalin—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.0023	CcSEcCtD
Pregabalin—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00229	CcSEcCtD
Pregabalin—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00229	CcSEcCtD
Pregabalin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.00225	CcSEcCtD
Pregabalin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00217	CcSEcCtD
Pregabalin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00216	CcSEcCtD
Pregabalin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00212	CcSEcCtD
Pregabalin—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.0021	CcSEcCtD
Pregabalin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00209	CcSEcCtD
Pregabalin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00208	CcSEcCtD
Pregabalin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00206	CcSEcCtD
Pregabalin—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00204	CcSEcCtD
Pregabalin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00203	CcSEcCtD
Pregabalin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.002	CcSEcCtD
Pregabalin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00199	CcSEcCtD
Pregabalin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00199	CcSEcCtD
Pregabalin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00197	CcSEcCtD
Pregabalin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00195	CcSEcCtD
Pregabalin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00191	CcSEcCtD
Pregabalin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.0019	CcSEcCtD
Pregabalin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00188	CcSEcCtD
Pregabalin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00188	CcSEcCtD
Pregabalin—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00187	CcSEcCtD
Pregabalin—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00185	CcSEcCtD
Pregabalin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00183	CcSEcCtD
Pregabalin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00182	CcSEcCtD
Pregabalin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00182	CcSEcCtD
Pregabalin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00177	CcSEcCtD
Pregabalin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00176	CcSEcCtD
Pregabalin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00175	CcSEcCtD
Pregabalin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00173	CcSEcCtD
Pregabalin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00173	CcSEcCtD
Pregabalin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00173	CcSEcCtD
Pregabalin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00172	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00172	CcSEcCtD
Pregabalin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00171	CcSEcCtD
Pregabalin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00169	CcSEcCtD
Pregabalin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00167	CcSEcCtD
Pregabalin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00166	CcSEcCtD
Pregabalin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00166	CcSEcCtD
Pregabalin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00165	CcSEcCtD
Pregabalin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00162	CcSEcCtD
Pregabalin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00162	CcSEcCtD
Pregabalin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00161	CcSEcCtD
Pregabalin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0016	CcSEcCtD
Pregabalin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00158	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00151	CcSEcCtD
Pregabalin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0015	CcSEcCtD
Pregabalin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00149	CcSEcCtD
Pregabalin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00148	CcSEcCtD
Pregabalin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00147	CcSEcCtD
Pregabalin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00144	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00143	CcSEcCtD
Pregabalin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00143	CcSEcCtD
Pregabalin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00142	CcSEcCtD
Pregabalin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00142	CcSEcCtD
Pregabalin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00137	CcSEcCtD
Pregabalin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00135	CcSEcCtD
Pregabalin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00132	CcSEcCtD
Pregabalin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00131	CcSEcCtD
Pregabalin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00131	CcSEcCtD
Pregabalin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00122	CcSEcCtD
Pregabalin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00119	CcSEcCtD
Pregabalin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00117	CcSEcCtD
Pregabalin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00113	CcSEcCtD
Pregabalin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0011	CcSEcCtD
Pregabalin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00105	CcSEcCtD
Pregabalin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00104	CcSEcCtD
Pregabalin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00104	CcSEcCtD
Pregabalin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00104	CcSEcCtD
Pregabalin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000962	0.000984	CcSEcCtD
